Conference

Bergen Fibrosis Conference, 2019

Novel tools to study the fibrotic stroma

Photo:

Torstein Ravnskog, UiB

1/2

Photo:

Torstein Ravnskog, UiB

2/2

Main content

SIU Fibrosis conference, May 23-24, 2019

Bergen

Venue: Grand Hotel Terminus, Zander Kaaes gate 6

Organizer: Donald Gullberg

May 23th	Session 1a. Cell-ECM interactions I - Chair: C. McCulloch (UoT)
8.30 – 9.10	1. Donald Gullberg, University of Bergen Integrin α11β1 - a fibroblast protein with a role in fibrosis
9.15 – 9.55	2. Ritva Heljasvaara, Univ. of Oulu Of mice, men and clouds - new target molecules in the tumor ECM
10.00-10.20	Coffee
	Session 1b. Cell-ECM interactions II - Chair: V. Weaver (UCSF)
10.20-11.00	3. Christopher McCulloch, University of Toronto Role of Flightless in Remodeling of the Fibrotic Stroma
11.05-11.45	4. John Marshall, Barts Cancer Institute The Role of integrins in regulation of the stroma
11.50-12.30	5. Sergey Plotnikov, Toronto Calcium Sparks in Focal Adhesions Drive Cell Migration Along ECM Stiffness Gradients
12.30-13.10	Lunch
	Session 2a. Mechanism of fibrosis I - Chair: R. Heljasvaara (Oulu)
13.10-13.50	6. Geir Christensen, Oslo Myocardial fibrosis in heart failure: mechanisms and functional consequences
13.55-14.25	7. Andreas Romaine, Oslo Syndecan-4 and Integrins: key regulators of the cardiac fibrotic response to pressure overload
14.30-15.00	8. Mari Elen Strand, Oslo Heparanase: a novel regulator of cardiac inflammation and fibrosis?
15.05-15.25	Coffee
	Session 2b. Tumor stroma associated fibrosis I - Chair: D. Gullberg (UiB)
15.25-16.05	9. Arne Östman, KI Clinically relevant marker- and pathway-defined subsets of cancer-associated fibroblasts
16.10-16.50	10. Agnes Noel, Liege Alpha 11 integrin interacts with PDGFRbeta receptor in pro-invasive breast cancer-associated fibroblasts
16.55-17.10	11. Jason Northey, UCSF Matrix stiffness and breast cancer risk
17.15-17.45	Business meeting SIU
19.30	Dinner (for speakers and invited guests)
May 24th	Session 3a. Mechansim of fibrosis II - Chair: R. Navab (UoT)
8.30-9.10	12. Reetta Hinttala, Oulu Dysfunction of human NHLRC2 as a cause of fibrosis, neurodegeneration and cerebral angiomatosis (FINCA)
9.15-09.55	13. Valerie Weaver, UCSF Reciprocal interplay between tumor immunity and fibrosis
10.00-10.20	Coffee
	Session 3b. Tumor stroma associated fibrosis II - Chair: A. Östman (KI)
10.20-10.50	14. Kristian Pietras, Lund, Sweden Microenvironmental control of malignant phenotypes
10.55-11.30	15. Daniel Öhlund, Umeå, Sweden Deciphering the extracellular matrix composition in pancreatic cancer
11.35-12.15	16. Roya Navab, Toronto The lysyl oxidase like-1 promotes non-small cell lung cancer tumorigenicity through increased matrix re-organization
12.20-13.00	Lunch
	Session 4. Emerging anti-fibrotic therapies - Chair: M. Fabre
13.00-13.40	17. Christian Klein, Roche Pharmaceutical Research, Switzerland Targeting tumor fibroblasts for cancer immunotherapy
13.45-14.25	18. Myriam Fabre, Oncomatryx Biopharma, Spain Tumor microenvironment-targeted biologics for cancer treatment
14:30-14.45	Coffee
14.45-15.25	19. Wolfgang Jarolimek, Pharmaxis, Australia Efficacy of pan- and selective lysyl oxidase inhibitors in reducing fibrosis
15.25-16.00	Discussion

Conference

23.05.2019 - 08.00–24.05.2019 - 16.00

Hotel Terminus, Bergen, Norway

Elon Donald Gullberg

Registration deadline

30.04.2019 - 23.59

Add to calendar

Confirmed speakers

Geir Christensen, UiO
Donald Gullberg, UiB
John Marshall, Barts Cancer Institute, UK
Christopher McCulloch, Toronto
Roya Navab, Toronto
Kristian Pietras, Lund University
Valerie Weaver, UCSF
Arne Östman, Karolinska Institute
Ritva Heljasvaara, Univ. of Oulu
Sergey Plotnikov, Toronto
Agnes Noel, Liege
Reetta Hinttala, Oulu
Daniel Öhlund, Umeå, Sweden